Results 101 to 110 of about 9,307,341 (282)
A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn’s disease [PDF]
, 2014 Background: The faecal calprotectin (FC) test is a non-invasive marker for gastrointestinal inflammation. Aim: To determine whether higher FC levels in individuals with quiescent Crohn’s disease are associated with clinical relapse over the ensuing 12 ...
Allan J. Morris +50 more
core +1 more source
Two Cases of Crohn's Disease Treated by Right Hemicolectomy [PDF]
, 1950 Ronald W. Raven
openalex +1 more source
Corticosteroids and corticotrophin in the treatment of Crohn's disease. [PDF]
, 1966 Jony Jones, J E Lennard-Jones
openalex +1 more source
Immunotherapy of Crohn′s disease
Mediators of Inflammation, 1998 Although the initiating events of Crohn′s disease are unknown, models of experimental colitis have provided new insights in the immunologically mediated pathways of mucosal inflammation. In Crohn′s disease activated mucosal T lymphocytes produce proinflammatory cytokines within the mucosal compartment. With this understanding, there has been a shift in
van Montfrans, C. +2 more
openaire +6 more sources
Cellular hypersensitivity to components of intestinal mucosa in ulcerative colitis and Crohn's disease [PDF]
, 1969 G Bendixen
openalex +1 more source
Folate deficiency in Crohn's disease: incidence, pathogenesis, and treatment. [PDF]
, 1968 A. Victor Hoffbrand +3 more
openalex +1 more source
Familial Prevalence of Inflammatory Bowel Disease in Northern Alberta
Canadian Journal of Gastroenterology, 1990 Previous studies have reported a high prevalence of inflammatory bowel disease among the relatives, and especially siblings, of patients with Crohn's disease or ulcerative colitis.
BR Pinchbeck, J Kirdeikis, ABR Thomson
doaj +1 more source